Brighton Jones’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Brighton Jones's MRNA Position: Q3 2026 in Review
Brighton Jones opened a new position in Moderna (MRNA) in Q3 2026: 2,575 shares worth $496K. The stake represents 0.01% of the portfolio and ranks #815 among its holdings. This is a return to the name: Brighton Jones previously reported a position in MRNA as recently as Q1 2023.
Brighton Jones first reported a position in MRNA in Q2 2020 and has held it in 12 quarters since. The position peaked at $664K in Q3 2021. 1,028 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Brighton Jones held 2,575 shares of Moderna worth $496K as of Q3 2026.
- Moderna was a new Brighton Jones position in Q3 2026.
- Moderna made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #815 holding.
- Brighton Jones first reported a position in Moderna in Q2 2020 and has held it in 12 quarters since.
- Brighton Jones's Moderna position peaked at $664K in Q3 2021.
- 1,028 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.